T 0063/20 (Formulation comprising ezetimibe / RATIOPHARM) of 09.03.2023
- European Case Law Identifier
- ECLI:EP:BA:2023:T006320.20230309
- Date of decision
- 9 March 2023
- Case number
- T 0063/20
- Online on
- 30 March 2023
- Petition for review of
- -
- Application number
- 08859677.0
- IPC class
- A61K 9/20A61K 31/397
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- PHARMACEUTICAL FORMULATION COMPRISING EZETIMIBE
- Applicant name
- ratiopharm GmbH
- Opponent name
- HGF Limited
Hoffmann Eitle
Bülle Dr., Jan
Wittkopp, Alexander - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- Rules of procedure of the Boards of Appeal 2020 Art 012(4)European Patent Convention Art 123(2)European Patent Convention Art 84European Patent Convention R 43(6)Rules of procedure of the Boards of Appeal 2020 Art 011European Patent Convention Art 111(1)
- Keywords
- Late-filed evidence - admitted (yes)
Amendments - main request
Amendments - allowable (yes)
Claims - clarity
Claims - main request (yes)
Remittal - special reasons for remittal - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The decision under appeal is set aside.
The case is remitted to the opposition division for further prosecution.